1 employees
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.
2021
$3.7M
from 3 investors over 3 rounds
Nexosome Oncology raised $3.7M on November 22, 2021
Investors: Keyhorse Capital, OCA Ventures and -